BLRX Stock Analysis: Buy, Sell, or Hold?
BLRX - BioLineRX Ltd
$3.28
-0.11 (-3.24%)
▼
5d:
-2.67%
30d:
+7.89%
90d:
+16.73%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 27, 2026
0d
Get Alerted When BLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BLRX is currently trading at $3.28, which is considered slightly high relative to its 30-day fair value range of $2.74 to $3.38.
Technical Outlook: Technically, BLRX is showing sideways momentum. Immediate support is located at $2.62, while resistance sits at $3.95. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: BLRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+433.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLRX is showing sideways momentum. Immediate support is located at $2.62, while resistance sits at $3.95. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: BLRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+433.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.74 -
$3.38
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 433.5% below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$2.74 -
$3.38
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.62
Resistance Level
$3.95
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.90
Wall Street Target
$17.50
(+433.5%)
Revenue Growth (YoY)
87.1%
Share & Embed Analysis
Last updated: June 03, 2026 8:41 PM ET
Data refreshes hourly during market hours. Next update: 9:41 PM
Data refreshes hourly during market hours. Next update: 9:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$446 | 60 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 48 HOLD |
